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AbstrAct
Introduction In low-resource countries, respiratory 
failure is associated with a high mortality risk among 
critically ill children. We evaluated the role of bubble 
continuous positive airway pressure (bCPAP) in the 
routine care of critically ill children in Lilongwe, Malawi.
Methods We conducted an observational study 
between 26 February and 15 April 2014, in an urban 
paediatric unit with approximately 20 000 admissions/
year (in-hospital mortality <5% approximately during 
this time period). Modified oxygen concentrators or 
oxygen cylinders provided humidified bCPAP air/oxygen 
flow. Children up to the age of 59 months with signs of 
severe respiratory dysfunction were recruited. Survival 
was defined as survival during the bCPAP-treatment 
and during a period of 48 hours following the end of the 
bCPAP-weaning process.
results 117 children with signs of respiratory failure 
were included in this study and treated with bCPAP. 
Median age: 7 months. Malaria rapid diagnostic tests 
were positive in 25 (21%) cases, 15 (13%) had severe 
anaemia (Hb < 7.0 g/dL); 55 (47%) children had 
multiorgan failure (MOF); 22 (19%) children were HIV-
infected/exposed. 28 (24%) were severely malnourished. 
Overall survival was 79/117 (68%); survival was 54/62 
(87%) in children with very severe pneumonia (VSPNA) 
but without MOF. Among the 19 children with VSPNA 
(single-organ failure (SOF)) and negative HIV tests, all 
children survived. Survival rates were lower in children 
with MOF (including shock) (45%) as well as in children 
with severe malnutrition (36%) and proven HIV infection 
or exposure (45%).
conclusion Despite the limitations of this study, the 
good outcome of children with signs of severe respiratory 
dysfunction (SOF) suggests that it is feasible to use bCPAP 
in the hospital management of critically ill children in 
resource-limited settings. The role of bCPAP and other 
forms of non-invasive ventilatory support as a part of 
an improved care package for critically ill children with 
MOF at tertiary and district hospital level in low-resource 
countries needs further evaluation. Critically ill children 
with nutritional deficiencies and/or HIV infection/exposure 
need further study to determine bCPAP efficacy.
IntroductIon
In 2015, 5.9 million children died before the 
age of 5 years with approximately 50% of 
these deaths occurring in sub-Saharan Africa 
(SSA).1 Very severe pneumonia (VSPNA) 
based on the WHO classification remains a 
leading cause of child mortality.1 Although 
there has been a considerable decline in 
mortality in hospitalised Malawian children 
between 2000 and 2012, mortality remained 
high in 2012 in critical subgroups including 
those with VSPNA (12%), severe undernu-
trition (15%) and severe acute malnutrition 
(35%).2 Despite the introduction of Haemo-
philus influenzae B and pneumococcal conju-
gate vaccines, severe respiratory infections 
(bacterial and viral) are likely to remain a 
major cause of morbidity and mortality in 
Key messages
 ► The high survival rates among children with very se-
vere pneumonia and no other severe organ dysfunc-
tions, documented in this study, indicate that bCPAP 
can be used safely and efficiently in resource-limited 
but well-supervised paediatric units in SSA.
 ► Multiorgan failure, malnutrition and HIV infection/ex-
posure were associated with an increased mortality 
risk. The role of bCPAP and other forms of NIV as a 
part of an improved care package for malnourished 
and non-malnourished critically ill children (includ-
ing shock ± anaemia) needs further evaluation.
 ► The study highlights the importance of a multidisci-
plinary approach in the implementation process of 
basic paediatric critical care measures like bCPAP, 
e.g.: efficient logistic set-up of patient circuits, re-
liable oxygen systems including reliable electricity 
supply, cost-effective, good quality medical equip-
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SSA. Paediatric emergency and critical care, adapted 
to available resources, is therefore essential in order to 
achieve further reductions in child mortality. Improve-
ments of non-invasive respiratory support can play an 
important role in this context.
Respiratory failure is also a common feature of criti-
cally ill children with severe sepsis.3 Severe infections 
can lead to a complex systemic inflammatory response, 
and a variety of conditions such as pneumonia, bacter-
aemia and malaria can coexist.4 5 Without early, efficient 
management, these infections can progress to significant 
organ dysfunction, including acute respiratory distress 
syndrome and respiratory failure.3 Respiratory support 
is therefore an essential element in the management of 
critically ill, septic children.6–8
Improved paediatric emergency care in health facilities 
and streamlined referral pathways can have a significant 
impact on child survival. Improvement of oxygen delivery 
and respiratory support plays an important role in this 
context. A recent study conducted in Malawi showed 
that the use of pulse oximetry in peripheral outpatient 
health facilities and village clinics can help clinicians 
and community health workers to identify children with 
severe pneumonia and hypoxaemia.9 A study in Papua 
New Guinea demonstrated that the reliable supply of low 
flow oxygen can reduce mortality among children with 
signs of severe pneumonia.10 Oxygen concentrators in 
conjunction with reliable electricity systems associated 
with ‘uninterruptable power supply' are cost-effective 
and provide a reliable method of oxygen supply in low-re-
source settings.11 12 Installation and maintenance of these 
‘oxygen systems’, however, remain a challenge in many 
health facilities in African countries.13 The combination 
of solar-powered energy systems and the use of oxygen 
concentrators can be an option to improve oxygen supply 
in health facilities in remote settings.14
Non-invasive respiratory support has the potential to 
improve the outcome of critically ill children managed 
in low-resource settings, and notably, the role of non-in-
vasive ventilatory (NIV) support in the management 
of septic children with ‘less severe Acute Respiratory 
Distress Syndrome (ARDS)’ is also under evaluation in 
high-resource settings.15
Different forms of NIV exist: continuous positive airway 
pressure (CPAP), high-flow of warmed and humidified 
air/oxygen via nasal cannula, bilevel positive airway pres-
sure and neuronally adjusted ventilatory assist.16 17
CPAP has been used efficiently for the treatment of 
children with respiratory dysfunction in high-resource 
settings (eg, viral bronchiolitis).18–20 It has been shown 
that bubble CPAP (bCPAP) administered through nasal 
prongs offers a good quality, relatively low-cost alterna-
tive to ventilator-delivered CPAP on neonatal units.21 
Feasibility and safety of bCPAP use on neonatal units in 
middle-income and low-income countries have also been 
evaluated.22
A recent randomised controlled trial (RCT) conducted 
in Bangladesh showed that children with VSPNA treated 
with bCPAP had a significantly lower mortality rate (4%) 
compared with a group treated with low-flow O2 (15%).
23 
A further study conducted in Ghana demonstrated that 
CPAP can be used efficiently in the management of chil-
dren with respiratory distress in SSA.24
A smaller study described the use of an improvised 
bCPAP set-up (mostly non-humidified flow) on an 
extremely busy paediatric unit in Malawi for children (29 
days to 59 months) with VSPNA and children presenting 
with signs of respiratory dysfunction in the context of 
critical illness (eg, severe malaria) including shock and 
severe anaemia.25 Several months later, the authors had 
the opportunity to introduce a better adapted bCPAP 
set-up in the same clinical environment. Its use with a 
larger and better-described cohort, and its success or 
failure dependent on patient risk characteristics and 
their association with death while on bCPAP, is reported 
here.
Methods
study population and setting
We conducted an observational study of all children 
0–15 years treated with bCPAP between 26 February and 
15 April 2014 in the paediatric department at Kamuzu 
Central Hospital in Lilongwe, Malawi. In 2014, this 
department had approximately 20 000 paediatric admis-
sions of infants and children ages 0–15 years. This obser-
vational study was conducted during the peak of the 
malaria season in 2014, with >3000 admissions/month in 
March and April 2014 and a mortality rate of approxi-
mately 4%.26 Most newborns were treated on a dedicated 
neonatal unit. A small number of newborns born outside 
Kamuzu Central Hospital, received respiratory support 
with bCPAP on the paediatric unit. Only these newborns 
were included in the study.
Patients were initially screened in a triage/admis-
sion zone. Critically ill children with emergency signs27 
were managed in a ‘resuscitation zone (4 beds for 4, 
sometimes up to 16 patients)’. This area was directly 
connected to a ‘critical care/emergency zone’ (approx-
imately 16–18 beds—for up to 30–60 patients), where 
further basic critical care, according to WHO guide-
lines27 (including management of airway and breathing, 
intravenous or intraosseous fluids, blood transfusion, 
nutritional support, oral and intravenous medications), 
was provided. Approximately eight oxygen concentra-
tors, backed up with oxygen cylinders, were available. 
The oxygen flow provided by each of these devices can 
be split to deliver low-flow O2 to up to five patients.
This centralisation of basic critical care enabled a 
limited number of staff to provide the best possible 
management (including vital signs approximately 2–3 
times per day and more frequent monitoring in very 
sick patients) to a large number of critically ill children 
(nurse to patient ratio: 1:15–30, doctors/clinical officers: 
2–4 (day) and 1–2 (night); supervision by at least one 
consultant on site for 12 hours per day). In a six-bed ‘high 
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dependency unit (HDU)’, closer observation of selected 
critically ill children could be provided (spot-checks of 
vital signs approximately 2–4 hourly). The number of 
HDU beds was insufficient for the management of the 
large number of critically ill children.
Survival was defined as survival during the bCPAP treat-
ment and during a period of 48 hours following the end 
of the bCPAP-weaning process.
The unit’s policy was to offer HIV testing and counsel-
ling to every hospitalised child. However, because of the 
high workload and limited numbers of HIV counsellors 
not all admitted children were tested prior to death or 
discharge.
Basic ‘point of care tests’ were usually available, 
including malaria rapid diagnostics tests (MRDT), 
haemoglobin tests and blood sugar analysis. Further labo-
ratory tests like blood gases, electrolytes, renal and liver 
function, and full blood counts were not available. The 
blood bank was able to provide urgent whole blood trans-
fusions generally within 2–4 hours but at times there was 
more of a delay.
Basic bedside ultrasound and echocardiography 
helped to define thoracic and abdominal pathologies, 
cardiac function and congenital heart diseases. Access to 
chest X-rays was inconsistent.
definitions and comorbidities
VSPNA was diagnosed by the presence of cough or diffi-
culty breathing with either SpO2 <90%, central cyanosis, 
severe respiratory distress (very severe chest indrawing), 
danger signs such as inability to drink or breast feed, 
lethargy, and reduced level of consciousness. Multiorgan 
failure (MOF) was defined as having respiratory dysfunc-
tion with either cardiovascular dysfunction (including 
severe anaemia) or central nervous system dysfunction at 
the time of bCPAP initiation. Severe anaemia was defined 
as an Hb <7 g/dL or clinically when rapid point-of-care 
testing was not available. Central nervous system dysfunc-
tion was defined as a Blantyre Coma Scale ≤3 or status 
epilepticus.
HIV status was defined as ‘infected’ if a child <2 years 
had a positive DNA PCR test or a child ≥2 years had a 
positive rapid test. A child was considered to be HIV 
‘exposed’ if there was a positive rapid test for a child 
<2 years or a documented maternal positive test, but no 
DNA PCR had yet been performed.
Malaria was diagnosed by MRDT, and all children with 
malaria receiving bCPAP would have been found to have 
severe malaria by virtue of their respiratory distress, shock 
or neurological dysfunction.
Nutritional status was described as either normal, 
moderate acute malnutrition or severe acute malnutri-
tion by WHO guidelines when data—usually mid-upper 
arm circumference (MUAC)—were available.
Other comorbidities included congenital heart defects 
diagnosed by bedside echocardiography, cerebral palsy, 
spina-bifida, hydrocephalus, neuromuscular disorders 
and other forms of neurodisability, sickle cell disease, 
malignancy or clinically suspected tuberculosis.
Inclusion criteria and initiation of bcPAP
Critically ill children of any age were initiated on bCPAP 
if, after initial resuscitation, they were found to have 
severe respiratory distress with or without further organ 
dysfunctions like shock, severe anaemia or neurological 
dysfunction. bCPAP could be initiated in the emergency 
zone or HDU depending on bed availability.
Fluid resuscitation
Children with signs of shock and no signs of dehydra-
tion received only careful fluid resuscitation (10 mL/
kg isotonic crystalloid solution). After re-evaluation, one 
further fluid bolus was administered in some children 
(a third bolus was only given very rarely). Malnourished 
children with signs of shock and no dehydration received 
only one fluid bolus. If possible, haemoglobin (Hb) was 
rechecked after each fluid bolus.
Children with severe anaemia did not receive a 
pre-transfusion bolus. In case of severe anaemia, 20 mL/
kg whole blood was transfused over 3–4 hours if HBs were 
<5–6 g/dL. This practice is in line with the latest WHO 
recommendations from 2016.28
In case of severe dehydration, WHO guidelines for the 
management of malnourished and non-malnourished 
children were followed as well.28
bcPAP device (see figure 1)
The low-cost bCPAP devices used in this study were modi-
fied oxygen concentrators with a maximum air/oxygen 
flow of 16 litres per min (LPM) (maximum oxygen flow: 
8 LPM, maximum air flow: 8 LPM; http:// go. gomango. 
co. uk/ diamedica. co. uk/ english/ product_ details_ 
diamedica. cfm? id= 1562). The FiO2 could be determined 
by adjusting the ratio of oxygen/air flow. The blended 
flow was humidified and in some devices could be 
warmed using the heat produced by the compressor of 
the oxygen concentrator. The pressure was determined 
by the distance of the distal part of the expiratory limb of 
the ventilation circuit below the water surface of a water 
bottle (‘resistor’).
In case not enough ‘bCPAP set-ups’ were available, 
oxygen cylinders were used to provide O2 flow required 
to provide bCPAP. With this ‘suboptimal set-up’, the 
FiO2 could not be adapted but oxygen flow could still 
be humidified. Patients were switched to the described 
‘modified oxygen concentrator’ whenever such a device 
was available.
Basic further care of critically ill children managed with bCPAP
Additional aspects of care for patients on bCPAP 
included head-up positioning, nasogastric tube (NGT) 
insertion for initial gastric decompression and drainage, 
intravenous maintenance fluids initially at 2/3 of the 
 o
n




pen Resp Res: first published as 10.1136/bmjresp-2018-000280 on 8 March 2019. Downloaded from 
4 Myers S, et al. BMJ Open Resp Res 2019;6:e000280. doi:10.1136/bmjresp-2018-000280
Open access
Figure 1 Bubble continuous positive airway pressure (bCPAP) set-up. (With permission of Diamedica: http://go.gomango.
co.uk/diamedica.co.uk/english/product_details_diamedica.cfm?id=1562)
‘4-2-1 rule’29 were administered. Isotonic electrolyte 
solutions (Ringers lactate and dextrose)30 were used as 
maintenance fluids. Once vital organ functions were 
stabilised, 3-hourly NGT feeds were introduced gradu-
ally with expressed breast milk for infants, F-75 for chil-
dren>6 months with SAM. Regarding enteral nutrition 
of critically ill children without severe acute malnutri-
tion (SAM): Not enough therapeutic nutrition (F75 or 
F100) was available for the nutrition of critically ill chil-
dren without SAM. No other specific enteral nutrition 
was available for this purpose. Therefore ordinary milk 
products or porridge were used for gastric tube feeding 
of these critically ill children. In many cases, tolerance 
of enteral feeds was initially tested with the administra-
tion of oral rehydration fluids via NGTs. The maximum 
volume of enteral feeds administered during this ‘critical 
care phase’ for malnourished and non-malnourished 
children was 100% according to the ‘4-2-1 rule’29.
National and WHO guidelines were applied to treat 
tuberculosis, HIV, malnutrition and common condi-
tions like severe malaria, respiratory infections, diarrheal 
diseases, meningitis and bacterial sepsis.27
Monitoring and vital signs
Rapid clinical screening was done to triage patients 
requiring non-invasive respiratory support. Basic vital 
signs (heart rate (HR), respiratory rate (RR), oxygen 
saturation (SpO2), temperature) were monitored usually 
2–3 times per day by vital signs assistants31 or qualified 
nurses.
cPAP settings
bCPAP pressure was commenced at 6–7 cm H2O.
19 The 
initial FiO2 was set at approximately 0.6%. Pressure 
and FiO2 were adjusted depending on signs of work of 
breathing and peripheral oxygen saturation measure-
ment by pulse oximetry (SpO2). The aim was to maintain 
SpO2 >94%. bCPAP pressure was usually kept ≤8 cm H2O 
and only in rare cases increased to 10 cm H2O. Humidi-
fied air/oxygen flow was used for all children.
bcPAP weaning protocol
When using the modified oxygen concentrator set-up, 
FiO2 was reduced when SpO2 was consistently >94% 
(FIO2 could not be adapted if O2 cylinders were used as 
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flow generator). If work of breathing and RR improved 
with SpO2 remaining consistently >94% (with an FIO2 
≤0.5%) bCPAP pressures were reduced gradually. If the 
patient remained stable and the bCPAP level was ≤5 cm 
H2O (with an FIO2 <0.3-0.4), then a trial ‘off bCPAP’ 
was started and the child was placed on low-flow oxygen 
(1–2 LPM). In cases of clinical deterioration, bCPAP was 
restarted. This clinical scenario was not considered as a 
‘treatment failure’. In the data analysis, this additional 
phase of ‘bCPAP management’ was considered as part of 
the ‘bCPAP weaning process’ and the initial treatment. 
The duration of the weaning process was depending on 
the child’s clinical progress. In the data analysis, the end 
of the weaning process was documented as the end of the 
bCPAP treatment.
data collection and analysis
A case record form, an observation chart and a patient 
register were used for data collection. Data were entered 
into an Excel database. We describe the proportion 
of bCPAP cases who survived by risk group, sex, age, 
complications, HIV status and treatment methods. We 
conducted univariable logistic regression to determine 
if the odds of bCPCP survival were higher in particular 
subgroups. The small number of cases precluded multi-
variable analysis. We also present a breakdown of survival 
and death (failure) by HIV status and comorbidities 
including shock, malaria, anaemia, MOF and severe 
malnutrition, and describe the reasons for complications 
of treatment. This study was done in a routine setting 
without dedicated funding and did not have a target 
sample size. The sample includes most bCPAP cases seen 
between 26 February and 15 April 2014. All analyses were 
done in Stata V.14.2 for Mac.
results
A total of 117 patients were included and 79 (68%) 
survived (table 1). Survival was similar among males and 
females, and did not differ statistically by age group, 
though there were small sample sizes in each group. 
Survival was lower in those with MOF (45%) than those 
with single-organ failure (SOF) and no comorbidities 
(86%; p<0.0001, table 1). Survival was also significantly 
lower in those with severe acute malnutrition (36%) than 
with no severe or moderate malnutrition (81%; table 1), 
and in those with confirmed HIV infection or exposure 
(45%) than those who were HIV negative (81%) or with 
an unknown HIV status (68%; table 1). There were no 
statistically significant differences in survival by bCPAP 
delivery device or treatment initiation location (table 1).
All 19 children with VSPNA who were HIV negative 
and had no comorbidities and no other organ dysfunc-
tions survived (five children in this group had suspected 
TB). Also, 40/42 (95%; 95% CI 84% to 99%) of children 
with VSPNA (unknown or negative HIV status) and no 
comorbidities and no other organ dysfunction survived. 
Children with VSPNA and HIV infection/exposure and/
or malnutrition had significantly increased mortality risk 
(see table 2). Respiratory failure with additional organ 
dysfunctions (shock, anaemia) was associated with lower 
survival rates.
In total, 14/15 (93%) children with severe anaemia 
were transfused. Four out of seven with severe anaemia 
and shock survived. Also, 6 out of 14 children with 
anaemia who were transfused died. The one patient with 
severe anaemia who was not transfused survived. And, 
11 out of 15 children with severe anaemia had positive 
malaria tests. Also, 7 of these 11 children survived.
Among the 31 children with severe malaria, 24 had 
multiorgan dysfunction. In total, 14 of these 24 children 
survived. Of children with positive malaria tests, 11/31 
(35%) had signs of shock. Also, 5 of these 11 children 
survived.
technical issues and complications
The average flow set was 9.1 LPM (SD 2.0, range 5–16). 
The average starting pressure was 6.7 cm H2O (SD 1.0, 
range 4–9).
In total, 13/117 patients experienced equipment-re-
lated complications, including blocked nostrils (2) or 
nasal prongs (2), interruption of oxygen supply from 
depleted cylinder (2), nasal septum lesions (7) and aspi-
ration of feeds (1). One parent refused the continuation 
of bCPAP. Some patients had more than one complica-
tion. The total number of treatment failures among those 
experiencing complications was 3/13 patients.
dIscussIon
This basic observational study was conducted on a very 
busy paediatric unit in Malawi during peak malaria 
season.
We describe a group of children with a high mortality 
risk. Because of resource limitations, we took the 
approach of offering bCPAP to those children having the 
most severe clinical presentations.
In high-resource settings, a considerable number of 
the 62 children with respiratory dysfunction and the 55 
children with MOF potentially would have been mechan-
ically ventilated and would have received further critical 
care interventions in a paediatric intensive care unit 
(PICU).7
Context-adapted disease severity scores (comparable to 
Paediatric Index of Mortality (PIM)32/Pediatric Risk of 
Mortality Score (PRISM)33 -scores used in PICUs) based 
on parameters describing acute physiological status and 
underlying conditions (eg, HIV infection, nutritional 
status) can help to describe and compare cohorts of crit-
ically ill children and adults managed in low-resource 
settings. Further research in this context is needed.34–37
In the study setting, only some children could benefit 
from intubation and ventilation. Surveys highlight the 
challenges associated with the set-up of intensive care 
units providing mechanical ventilation of children. 
Significant resources will be directed to only a small 
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(%)* OR of death (95% CI)
Total 117 79 (68%) 38 (32%)
Demographics 
  Male† 58 40 (69%) 18 (31%) 1.00
  Female† 51 34 (67%) 17 (33%) 1.11 (0.50 to 2.49)
  Median (IQR) age in months 7 (2– 15) 6 (2–15) 7 (4–14)
Age (months)† 
  <1 6 3 (50%) 3 (50%) 1.00
  1–12 76 53 (70%) 23 (30%) 0.43 (0.81 to 2.31)
  13–24 23 17 (74%) 6 (26%) 0.35 (0.06 to 2.25)
  25–48 10 5 (50%) 5 (50%) 1.00 (0.13 to 7.57)
Organ failure 
  VSPNA 62 54 (87%) 8 (13%)
  VSPNA no comorbidities‡; including 
children<1 month
59 51 (86%) 8 (14%) 1.00
  VSPNA with comorbidities‡ 3 3 (100%) 0 (0%)
  VSPNA no comorbidities; no HIV 
exposure/infection, no malaria, no 
suspected TB‡
14 14 (100%) 0 (0%)
  VSPNA; no comorbidities; no HIV 
exposure/infection, no malaria; 
including suspected TB
19 19 (100%) 0 (0%)
  MOF >1 organ dysfunction‡: 
respiratory dysfunction and at least 
one further organ dysfunction
55 25 (45%) 30 (55%) vs VSPNA: 8.10 (3.25 to 
20.18)¶
  MOF >2 organ dysfunctions‡: 
(respiratory dysfunction and at least 
two other organ dysfunctions)
21 9 (43%) 12 (57%)
Malnutrition† 
  SAM 28 10 (36%) 18 (64%) 7.59 (2.88 to 19.97)§
  MAM 13 8 (62%) 5 (38%) 2.63 (0.75 to 9.29)
  No MAM or SAM 73 59 (81%) 14 (19%) 1.00
HIV status 
  Infected or exposed 22 10 (45%) 12 (55%) 4.97 (1.53 to 16.13)¶
  Negative 36 29 (81%) 7 (19%) 1.00
  Unknown 59 40 (68%) 19 (32%) 1.97 (0.73 to 5.29)
bCPAP delivery device 
  Cylinder 50 35 (70%) 15 (30%) 1.00
  Concentrator 48 30 (62%) 18 (38%) 1.40 (0.60 to 3.25)
  Unrecorded 17 12 (71%) 5 (29%) 0.97 (0.29 to 3.25)
Treatment initiation location 
  High dependency unit 29 17 (59%) 12 (41%) 1.55 (0.65 to 3.70)
  Emergency zone 83 57 (69%) 26 (31%) 1.00
Intubation** 
  No 100 77 (77%) 23 (23%) 1.00
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(%)* OR of death (95% CI)
  Median (IQR) treatment duration 
(hours)
24 (24–60) 24 (24–60) 24 (24–48)
Comorbidities: congenital heart diseases (4 (children with congenital heart diseases: AVSD: 2 (1 with trisomy 21), VSD: 1; PDA: 1 (and 
trisomy 21))), neurodisability (cerebral palsy (1), hydrocephalus (1), neuromuscular disorder (1), severe thorax wall infection/defect (1). 
bCPAP,bubble continuous positive airway pressure; HB, haemoglobin; MAM, moderate acutemalnutrition; MOF, multiorgan failure; SAM, 
severe acute malnutrition; TB,tuberculosis; VSPNA, very severe pneumonia. AVSD, Atrio-ventricular Septum Defect; VSD, Ventricular Septum 
Defect; PDA, Persistent Ductus Arteriosus
*The percentages given in column 3 and 4 describe the ratios to the subtotals documented in column 2.
†Information on sex (male/female) was not recorded for eight patients. Information on age was not recorded for two patients. Information on 
malnutrition (MAM or SAM) was not recorded for three patients.
‡Organ dysfunction: respiratory failure (signs of very severe pneumonia50, signs of shock or ‘impaired circulation’28, severe anaemia (HB< 7 
g/dl), coma/prolonged convulsions, clinical signs of liver/renal failure.
§p<0.0001.
¶p=0.008.
**In 2 of the 117 patients the information on potential intubation and ventilation was not documented.
††p<0.000.
bCPAP, bubble continuous positive airway pressure; HB, haemoglobin; MAM, moderate acutemalnutrition; MOF, multiorgan failure; SAM, 
severe acute malnutrition; TB, tuberculosis; VSPNA, very severe pneumonia.
Table 1 Continued
number of critically ill patients and specific skill levels 
are required.38–40 Routine mechanical ventilation of criti-
cally ill children is therefore not yet a feasible option for 
a large number of paediatric units in SSA.
A survey conducted on the same unit in 2012 using an 
improvised bCPAP set-up showed the following survival 
rates: overall survival—41/77 (53%), survival among chil-
dren with VSPNA—19/26 (73%) and VSPNA in HIV-neg-
ative children—14/17 (82%).25
Several factors could explain the improved outcome 
of patients with respiratory failure managed with bCPAP 
described in this publication. The disease severity of the 
cohorts described in this publication and the study from 
2012 are difficult to compare. Furthermore, in the 2-year 
interval between the studies training, senior supervision 
and paediatric emergency care was improved on the unit 
in Lilongwe. Introduction of conjugated pneumococcal 
vaccine in the routine vaccination schedule in Malawi in 
the time period between 2012 and 2014 could have had 
an impact on the spectrum of pathogens causing severe 
respiratory infections and other severe bacterial infec-
tions in young children. However, the improved bCPAP 
set-up including the use of humidified air/oxygen might 
have contributed to improved outcomes as well. There is 
considerable evidence indicating that the relatively high 
air/oxygen flow used in NIV should be ‘conditioned 
(warmed and humidified)’.41 42
The outcome of HIV-negative children with severe respi-
ratory dysfunction (SOF) managed with bCPAP in this 
study (mortality rate in this subgroup: 0%) is comparable 
to outcomes of children with respiratory failure managed 
with bCPAP in the context of an RCT recently conducted 
in Bangladesh (mortality rate: 4%).23 Outcomes of this 
subgroup indicate that the use of bCPAP as a form of NIV 
is feasible on a busy paediatric critical care department 
in SSA.
In high-resource settings, proactive respiratory 
support is standard care in the management of multi-
organ dysfunction.8 In this context, the role of NIV in 
less severe ARDS requires further evaluation.15 In low-re-
source settings, NIV has the potential to improve respira-
tory care for critically ill children, where options for safe 
mechanical ventilation are extremely limited.
An increased mortality risk among children with respi-
ratory dysfunction associated with severe malnutrition 
and/or HIV infection/exposure is suggested by this 
survey, as demonstrated in other studies.43 In total, 17 out 
of 28 children with SAM treated in this study had more 
than one organ dysfunction (eg, shock).
An RCT is currently being conducted in Malawi 
comparing the use of bubble CPAP and low-flow oxygen 
in children with respiratory failure with and without 
further organ dysfunctions, including children with HIV 
and malnutrition.44
Children who had their treatment initiated in the 
emergency zone had a higher survival rate than chil-
dren treated in the HDU. This difference was not statis-
tically significant. This ‘trend’ is likely to be explained 
by a significant selection bias with much sicker patients 
being treated in the HDU. The six-bedded HDU was 
certainly too small for a paediatric unit with around 20 
000 admissions per year. Following rapid identification 
further ‘context adapted’ critical care management in a 
‘HDU- setting’ is very likely to improve survival chances 
of critically ill children.
One child in this study suffered an episode of aspira-
tion. A recent study conducted in Australia showed that 
children requiring CPAP did not have an increased risk 
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of aspiration, apnoeas/hypoxic events when managed via 
NGT feeding compared with intravenous maintenance 
fluids.45 Because of limited monitoring options, we could 
not determine if some of the children had episodes of 
desaturation associated with NGT feeds. Careful moni-
toring of maintenance fluids and feeding practices are 
important elements to consider in the care of critically ill 
children in low-resource settings. We suggest that intro-
duction of enteral feeds in critically ill malnourished and 
non-malnourished children managed in low-resource 
settings should follow basic principles used in paedi-
atric intensive care. Enteral feeds for malnourished and 
non-malnourished children can be introduced gradually 
after stabilisation of vital organ functions (eg, stabilisa-
tion of respiratory function on O2 or bCPAP, correction 
of shock, anaemia and dehydration as well as a phase of 
stability of the child’s neurological function, even if still 
comatosed) and the absence of contraindications (eg, 
abdominal pathologies, large gastric aspirates).
In total, 11/117 children developed nasal prong-asso-
ciated problems such as obstruction of the nostrils/nasal 
prongs (4) or injury of the nasal septum (7). Improved 
interfaces can help in this context. Good nursing care 
and adequate nurse to patient ratios in a HDU setting 
are essential in order to reduce complication rates and 
achieve good outcomes in critically ill children treated 
with bCPAP. Efficient and sustained training programmes 
need to accompany the introduction of bCPAP. Care-
takers should be integrated in the care and should be 
encouraged to notify any concern regarding the condi-
tion of their child or any malfunctioning equipment.
Devices used for bCPAP and other forms of NIV in low 
resources need to be of good quality and should undergo 
independent biomedical review procedures.46 Biomed-
ical repair and maintenance arrangements need to be 
put in place. Infection prevention and control measures 
need to be established.
limitations
Interpretation of results is limited by the basic observa-
tional set-up of the study. The small sample size limited 
more detailed subgroup analyses. Data quality (eg, 
frequency of vital signs monitoring) was affected by 
limited human resources and equipment as well as the 
extremely high workload. Limited human resources also 
contributed to the fact that most, but not all, children 
who were managed with bubble CPAP during the study 
period were included in the analysis. Some ‘CPAP-runs’ 
of short duration might have been missed during week-
ends. However, we do not think that this contributed to 
a selection bias, which affected the outcome of the study.
Monitoring of essential elements of critical care 
management (eg, fluid management) was also affected 
by low health worker to patient ratio. Adequate numbers 
of well-trained health workers and basic equipment (eg, 
SpO2 monitors) can improve care packages and the 
potential positive impact of bCPAP on the outcome of 
critically ill patients with respiratory dysfunction. Labora-
tory tests allowing more detailed evaluation of renal and/
or hepatic dysfunction were not available. This might 
have contributed to an underestimation of the number 
of children presenting with MOF. Renal dysfunction is an 
important parameter determining mortality risk among 
critically ill children, including children with severe 
Malaria.47–49
Anthropometric measurements were suboptimal in 
our survey. In many children, we therefore used weight/
age as a marker of nutritional status.
conclusion
Despite the limitations of this study, the good outcome of 
children with signs of VSPNA suggests that it is feasible 
to use bCPAP in the hospital management of critically ill 
children in low-resource settings.
BCPAP and other forms of NIV can potentially play an 
important role in the improvement of care for critically 
ill children with respiratory failure and further organ 
dysfunction (eg, shock, severe anaemia) managed in 
low-resource settings. Further research is required in this 
context. Children with malnutrition and HIV infection 
or exposure need particular attention. Different disease 
processes like malaria, bacterial sepsis and dengue fever 
need to be considered.
The impact on patient outcome of different forms of 
NIV should be evaluated. Adapted, good quality equip-
ment with associated maintenance systems is required as 
well as adequate numbers of health workers and efficient, 
sustained training activities.
Author affiliations
1South Wales Deanery, Wales, UK
2Kamuzu Central Hospital, Lilongwe, Malawi
3United States Peace Corps, Washington, DC, USA
4Malawian College of Medicine, Lilongwe, Malawi
5Department of Pediatrics, University of Cincinnati, College of Medicine, 
Cincinnati, Ohio, USA
6Division of Emergency Medicine, Cincinnati Children Hospital Medical Center, 
Cincinnati, Ohio, USA
7University College London Institute for Global Health, London, UK
8John Hopkins University School of Medicine, Baltimore, Maryland, USA
9Ministry of Health, Lilongwe, Malawi
10Baylor College of Medicine, Children Clinical Centre of Excellence, Lilongwe, 
Malawi
11Centre for International Migration and Development (CIM)/German 
International Cooperation (GIZ), Eschborn, Germany
Acknowledgements The authors acknowledge the support of all the nurses, 
clinical officers, doctors and support staff working on the paediatric unit at KCH. 
They also thank all the children admitted to the paediatric unit and their guardians 
for their understanding and cooperation. They acknowledge the contribution of 
Paul Sonnenstuhl and Lukas Lang, who supported the data collection and logistic 
aspects of the study.
contributors SM: with the support of H-JL she set-up the 'survey structure', 
including data collection (case record forms, documentation of vital signs and 
management, etc). She was also involved in the clinical management of patients 
and clinical training of nurses, clinicians and students. Together with H-JL she 
wrote the initial draft of the manuscript and finalised the publication. PDPD 
contributed to the nursing care of patients, documentation of patient information, 
vital signs and management. PD contributed also to practical training of nurses 
regarding general patient care and specifically on the use of bCPAP. She was of 
 o
n




pen Resp Res: first published as 10.1136/bmjresp-2018-000280 on 8 March 2019. Downloaded from 
10 Myers S, et al. BMJ Open Resp Res 2019;6:e000280. doi:10.1136/bmjresp-2018-000280
Open access
great value in the communication with parents and caretakers. MA and CS gave 
advice on the 'set-up of the survey'. They contributed to the care of patients, 
training of nurses and clinicians. They also made very important suggestions on the 
manuscript of the publication. RM advised on the 'set-up' of the survey. She made 
vital contributions to the introduction to bCPAP on the department’s neonatal unit. 
She was involved in patient care, training of clinicians, nurses and students. RM 
made important comments on the manuscript of the publication. AP advised on the 
'set-up' of the survey. He contributed to patient care and training of health workers 
and students. AP made important comments on the manuscript of the publication. 
TC contributed to 'set-up' of the survey regarding rational data collection under 
the given circumstances. He was responsible for data analysis and contributed 
to the write-up of the manuscript. EDM contributed to the introduction of bCPAP 
in Malawi (Lilongwe) and advised on the 'set-up' of the survey. He supported 
the write-up of the manuscript and interpretation of results. CM advised on the 
'set-up' of the survey and supported the survey on administrative level. He made 
valuable contributions to the manuscript. PK advised on the 'set-up' of the survey 
and supported the survey on administrative level. He made valuable contributions 
to the manuscript. He also gave advice on the case management of critically ill 
children. H-JL contributed to the introduction of bCPAP in Malawi (Blantyre and 
Lilongwe) and initiated this and a previous survey conducted on the same unit. He 
contributed to logistic improvements of the department´s paediatric emergency 
unit and the management of critically ill children. He was involved in the training of 
clinicians, nurses and students. Together with SM he wrote the initial draft of the 
manuscript and finalised the publication. H-JL might include this publication in a 
portfolio required for an academic degree.
Funding The authors have not declared a specific grant for this research from any 
funding agency in the public, commercial or not-for-profit sectors.
competing interests None declared.
Patient consent for publication Not required.
ethics approval Malawian National Health Sciences and Research Committee, 
protocol number 941.
Provenance and peer review Not commissioned; externally peer reviewed.
data sharing statement The authors are willing to share management protocols, 
data collection tools, data and any other relevant information associated with this 
observational study on demand.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the 
use is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
RefeRenCes
 1. Liu L, Oza S, Hogan D, et al. Global, regional, and national 
causes of child mortality in 2000–13, with projections to inform 
post-2015 priorities: an updated systematic analysis. The Lancet 
2015;385:430–40.
 2. Lazzerini M, Seward N, Lufesi N, et al. Mortality and its risk factors 
in Malawian children admitted to hospital with clinical pneumonia, 
2001-12: a retrospective observational study. Lancet Glob Health 
2016;4:e57–e68.
 3. Kissoon N, Uyeki TM. Sepsis and the global burden of disease in 
children. JAMA Pediatr 2016;170:107.
 4. Takem EN, Roca A, Cunnington A. The association between malaria 
and non-typhoid Salmonella bacteraemia in children in sub-Saharan 
Africa: a literature review. Malar J 2014;13:400.
 5. Church J, Maitland K. Invasive bacterial co-infection in African 
children with Plasmodium falciparum malaria: a systematic review. 
BMC Med 2014;12:31.
 6. Rimensberger PC, Cheifetz IM. Ventilatory support in children with 
pediatric acute respiratory distress syndrome. Pediatr Crit Care Med 
2015;16:S51–S60.
 7. Barry P, Morris K, Tariq A. Oxford specialist handbook: paediatric 
intensive care. Oxford University Press, 2010.
 8. Davis AL, Carcillo JA, Aneja RK, et al. American college of critical 
care medicine clinical practice parameters for hemodynamic 
support of pediatric and neonatal septic shock. Crit Care Med 
2017;45:1061–93.
 9. McCollum ED, King C, Deula R, et al. Pulse oximetry for children 
with pneumonia treated as outpatients in rural Malawi. Bull World 
Health Organ 2016;94:893–902.
 10. Duke T, Wandi F, Jonathan M, et al. Improved oxygen systems for 
childhood pneumonia: a multihospital effectiveness study in Papua 
New Guinea. The Lancet 2008;372:1328–33.
 11. Bradley BD, Light JD, Ebonyi AO, et al. Implementation and 8-year 
follow-up of an uninterrupted oxygen supply system in a hospital in 
The Gambia. Int J Tuberc Lung Dis 2016;20:1130–4.
 12. World Health Organisation. WHO technical specifications for oxygen 
concentrators. WHO, 2016.
 13. Belle J, Cohen H, Shindo N, et al. Influenza preparedness in low-
resource settings: a look at oxygen delivery in 12 African countries. J 
Infect Dev Ctries 2010;4:419–24.
 14. Duke T, Hwaihwanje I, Kaupa M, et al. Solar powered oxygen 
systems in remote health centers in Papua New Guinea: a 
large scale implementation effectiveness trial. J Glob Health 
2017;7:010411.
 15. Essouri S, Carroll C. Noninvasive support and ventilation for 
pediatric acute respiratory distress syndrome. Pediatr Crit Care Med 
2015;16:S102–S110.
 16. Argent AC, Biban P. What's new on NIV in the PICU: does everyone 
in respiratory failure require endotracheal intubation? Intensive Care 
Med 2014;40:880–4.
 17. Morley SL. Non-invasive ventilation in paediatric critical care. 
Paediatr Respir Rev 2016;20:24–31.
 18. Essouri S, Chevret L, Durand P, et al. Noninvasive positive pressure 
ventilation: five years of experience in a pediatric intensive care unit. 
Pediatr Crit Care Med 2006;7:329–34.
 19. Essouri S, Durand P, Chevret L, et al. Optimal level of nasal 
continuous positive airway pressure in severe viral bronchiolitis. 
Intensive Care Med 2011;37:2002–7.
 20. Essouri S, Laurent M, Chevret L, et al. Improved clinical and 
economic outcomes in severe bronchiolitis with pre-emptive nCPAP 
ventilatory strategy. Intensive Care Med 2014;40:84–91.
 21. Gupta S, Donn SM. Continuous positive airway pressure. Clin 
Perinatol 2016;43:647–59.
 22. Martin S, Duke T, Davis P. Efficacy and safety of bubble CPAP in 
neonatal care in low and middle income countries: a systematic 
review. Arch Dis Child - Fetal Neonatal 2014;99:F495–F504.
 23. Chisti MJ, Salam MA, Smith JH, et al. Bubble continuous positive 
airway pressure for children with severe pneumonia and hypoxaemia 
in Bangladesh: an open, randomised controlled trial. The Lancet 
2015;386:1057–65.
 24. Wilson PT, Baiden F, Brooks JC, et al. Continuous positive airway 
pressure for children with undifferentiated respiratory distress in 
Ghana: an open-label, cluster, crossover trial. Lancet Glob Health 
2017;5:e615–e623.
 25. Walk J, Dinga P, Banda C, et al. Non-invasive ventilation with bubble 
CPAP is feasible and improves respiratory physiology in hospitalised 
Malawian children with acute respiratory failure. Paediatr Int Child 
Health 2016;36:28–33.
 26. Lang H, Mlotha-Mitole R, Phiri A. ABSTRACT 34: reduction of 
paediatric hospital mortality in a malawian referral hospital. Pediatr 
Crit Care Med 2014;15:11–12.
 27. WHO. Pocket book of hospital care for children : guidelines for the 
management of common childhood illnesses, 2013.
 28. World Health Organization. Guideline: updates on paediatric 
emergency triage, assessment and treatment: care of critically-ill 
children, 2016.
 29. Holliday MA, Segar WE. The maintenance need for water in 
parenteral fluid therapy. Pediatrics 1957;19:823–32.
 30. McNab S, Duke T, South M, et al. 140 mmol/L of sodium versus 
77 mmol/L of sodium in maintenance intravenous fluid therapy for 
children in hospital (PIMS): a randomised controlled double-blind 
trial. The Lancet 2015;385:1190–7.
 31. Olson D, Preidis GA, Milazi R, et al. Task shifting an inpatient 
triage, assessment and treatment programme improves the quality 
of care for hospitalised Malawian children. Trop Med Int Health 
2013;18:879–86.
 32. Slater A, Shann F, Pearson G, et al. PIM2: a revised version of the 
paediatric index of mortality. Intensive Care Med 2003;29:278–85.
 33. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated 
pediatric risk of mortality score. Crit Care Med 1996;24:743–52.
 34. Olson D, Davis NL, Milazi R, et al. Development of a severity of 
illness scoring system (inpatient triage, assessment and treatment) 
for resource-constrained hospitals in developing countries. Trop 
Med Int Health 2013;18:871–8.
 35. Hooli S, Colbourn T, Lufesi N, et al. Predicting hospitalised paediatric 
pneumonia mortality risk: an external validation of risc and mrisc, 
and local tool development (RISC-Malawi) from Malawi. PLoS One 
2016;11:e0168126.
 36. Reed C, Madhi SA, Klugman KP, et al. Development of the 
Respiratory Index of Severity in Children (RISC) score among young 








pen Resp Res: first published as 10.1136/bmjresp-2018-000280 on 8 March 2019. Downloaded from 
Myers S, et al. BMJ Open Resp Res 2019;6:e000280. doi:10.1136/bmjresp-2018-000280 11
Open access
 37. Haniffa R, Isaam I, De Silva AP, et al. Performance of critical care 
prognostic scoring systems in low and middle-income countries: a 
systematic review. Crit Care 2018;22:18.
 38. Smith ZA, Ayele Y, McDonald P. Outcomes in critical care delivery at 
Jimma University Specialised Hospital, Ethiopia. Anaesth Intensive 
Care 2013;41:363–8.
 39. Dünser MW, Towey RM, Amito J, et al. Intensive care medicine in 
rural sub-Saharan Africa. Anaesthesia 2017;72:181–9.
 40. Argent AC, Ahrens J, Morrow BM, et al. Pediatric Intensive Care in 
South Africa. Pediatr Crit Care Med 2014;15:7–14.
 41. Esquinas Rodriguez AM, Scala R, Soroksky A, et al. Clinical review: 
Humidifiers during non-invasive ventilation - key topics and practical 
implications. Critical Care 2011;16:203.
 42. Chidekel A, Zhu Y, Wang J, et al. The effects of gas humidification 
with high-flow nasal cannula on cultured human airway epithelial 
cells. Pulm Med 2012;2012:1–8.
 43. Preidis GA, McCollum ED, Mwansambo C, et al. Pneumonia and 
malnutrition are highly predictive of mortality among African children 
hospitalized with human immunodeficiency virus infection or exposure 
in the era of antiretroviral therapy. J Pediatr 2011;159:484–9.
 44. Smith AG, Eckerle M, Mvalo T, et al. CPAP IMPACT: a protocol 
for a randomised trial of bubble continuous positive airway 
pressure versus standard care for high-risk children with severe 
pneumonia using adaptive design methods. BMJ Open Respir Res 
2017;4:e000195.
 45. Oakley E, Borland M, Neutze J, et al. Nasogastric hydration versus 
intravenous hydration for infants with bronchiolitis: a randomised 
trial. Lancet Respir Med 2013;1:113–20.
 46. Falk M, Donaldsson S, Drevhammar T. Infant CPAP for low-income 
countries: An experimental comparison of standard bubble CPAP 
and the Pumani system. PLoS One 2018;13:e0196683.
 47. Schneider J, Khemani R, Grushkin C, et al. Serum creatinine as 
stratified in the RIFLE score for acute kidney injury is associated with 
mortality and length of stay for children in the pediatric intensive 
care unit. Crit Care Med 2010;38:933–9.
 48. von Seidlein L, Olaosebikan R, Hendriksen IC, et al. Predicting 
the clinical outcome of severe falciparum malaria in african 
children: findings from a large randomized trial. Clin Infect Dis 
2012;54:1080–90.
 49. Conroy AL, Hawkes M, Elphinstone RE, et al. Acute Kidney Injury 
Is Common in Pediatric Severe Malaria and Is Associated With 
Increased Mortality. Open Forum Infect Dis 2016;3:ofw046.
 50. World Health Organisation. Revised WHO classification and 
treatment of childhood pneumonia at health facilities. WHO, 2014.
 o
n




pen Resp Res: first published as 10.1136/bmjresp-2018-000280 on 8 March 2019. Downloaded from 
